Beside other AH markers already described as potentially useful for diagnosis or reflecting response to RB treatment regimens [30,31,32,33],TFF1 is a new potential valuable biomarker for subtype 2 RBs [4]. This evidence concerns the gene TFF1 and retinoblastoma.